Key result
Cryo-EM reveals encephalomyocarditis virus IRES domain I contacts ribosomal proteins and initiator tRNA.
Why the study?
The mechanism and interactions by which domain I of Type 2 IRESs drives ribosomal attachment to eIF4G/eIF4A-bound IRESs were unknown.
This structural analysis reveals the molecular mechanism of ribosomal recruitment by Type 2 IRESs, demonstrating a novel direct interaction between the IRES GNRA tetraloop and initiator tRNA.
Opens new target axis for antivirals in viral myocarditis; extends mechanistic models of Type 2 IRES ribosomal recruitment.
The encephalomyocarditis virus (EMCV) internal ribosomal entry side (IRES) and other Type 2 IRESs favor translation of the viral genome during infection. The domains H-L of these IRESs specifically interact with the cellular translation initiation factors eIF4G/eIF4A through their essential JK domain. However, the JK domain is not sufficient for IRES activity, which also strictly requires the preceding domain I of unknown function. To identify interactions that drive ribosomal attachment to eIF4G/eIF4A-bound Type 2 IRESs, we determined the cryo-EM structure of 48S initiation complexes formed on the EMCV IRES. The apical cloverleaf of domain I contacts ribosomal proteins uS13 and uS19 via its subdomain Id, whereas the essential GNRA tetraloop in subdomain Ic interacts with the TψC domain of initiator tRNA. The IRES-tRNA interaction also provides a mechanism for release of the IRES after eIF2 is replaced by eIF5B during subunit joining to allow attachment of 60S subunits. Functional assays supported the exceptional role of these interactions for initiation on this IRES. The strong conservation of the apex of domain I amongst Type 2 IRESs suggests that the reported interactions provide a common general mechanism of ribosomal attachment on them all.
No takes yet. Share an insight, caveat, or question.
Bhattacharjee et al. (2026) studied this question. Cryo-EM of the encephalomyocarditis virus IRES 48S complex showed domain I's apical cloverleaf contacts ribosomal proteins uS13 and uS19, and its GNRA tetraloop interacts with initiator tRNA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: